PHARVARIS NV (PHVS)
NL00150005Y4 - Common Stock
ChartMill assigns a Buy % Consensus number of 85% to PHVS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 34.97. This target is 82.52% above the current price.
PHVS was analyzed by 13 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about PHVS.
In the previous month the buy percentage consensus was at a similar level.
PHVS was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-15 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-04-11 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-04-11 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-03-19 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-02-14 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-01-23 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2023-12-07 | B of A Securities | Maintains | Underperform -> Underperform |
| 2023-12-07 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-11-14 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-11-03 | Wedbush | Maintains | Outperform -> Outperform |
| 2023-09-25 | Wedbush | Initiate | Outperform |
| 2023-08-15 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
| 2023-08-01 | Morgan Stanley | Reiterate | Equal-Weight -> Equal-Weight |
| 2023-07-31 | Morgan Stanley | Reiterate | Equal-Weight -> Equal-Weight |
| 2023-07-24 | Morgan Stanley | Reiterate | Equal-Weight -> Equal-Weight |
| 2023-07-17 | Morgan Stanley | Reiterate | Equal-Weight -> Equal-Weight |
| 2023-06-26 | Morgan Stanley | Reiterate | Equal-Weight -> Equal-Weight |
| 2023-06-20 | Morgan Stanley | Reiterate | Equal-Weight |
| 2023-06-12 | Morgan Stanley | Reiterate | Equal-Weight -> Equal-Weight |
| 2023-05-08 | JMP Securities | Reiterate | Market Outperform |
| 2023-04-06 | JMP Securities | Maintains | Market Outperform |
| 2023-02-27 | JMP Securities | Reiterate | Market Outperform |
| 2023-02-03 | SVB Leerink | Maintains | Outperform |
| 2023-01-11 | JMP Securities | Maintains | Market Outperform |
| 2022-12-09 | JMP Securities | Maintains | Market Outperform |
| 2022-09-14 | SVB Leerink | Maintains | Outperform |
| 2022-08-23 | Oppenheimer | Maintains | Outperform |
| 2022-08-23 | SVB Leerink | Maintains | Outperform |
| 2022-08-23 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2022-08-22 | B of A Securities | Downgrade | Neutral -> Underperform |